A Systematic Review on NSAID and Tanezumab efficacy in Chronic Lower Back Pain
Preprint
- 22 September 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Chronic back pain is an ailment that impacts people of all ages and lasts longer than 12 weeks. 7.41% of all Years Lost to Disability (YLD) are associated with low back pain, which makes it the pathology responsible for the most YLD, surpassing other chronic conditions such as Diabetes and Depression. Despite the prevalence of drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs), painkillers, and biologics, the types of drugs administered to individuals differ greatly. We collected data from the PubMed database of the PubMed database, National Library of Medicine (NIH), and Google Scholar. Randomized controlled trials (RCTs) that explicitly evaluate the effectiveness of various NSAIDs in adult patients with chronic back pain were selected for this study. After an exhaustive search and examination of numerous publications, only 8 articles met the inclusion criteria. In recent studies that included NSAIDs, they were among the most frequently prescribed medications for the treatment of chronic low back pain. In comparison to placebo, selective COX-II inhibitors such as celecoxib and etoricoxib were found to be efficacious, while valdecoxib was associated with serious side effects. In addition to reducing back pain, COX-II inhibitors with a preference for COX-II, such as aceclofenac and diclofenac, were associated with gastrointestinal side effects. Despite the risk of joint degeneration and accelerated osteoarthritis, intravenous tanezumab may be superior to naproxen and placebo in treating chronic low back pain.Keywords
All Related Versions
This publication has 17 references indexed in Scilit:
- Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled TrialArthritis Care & Research, 2016
- Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back painPain, 2013
- Efficacy and safety of tanezumab in the treatment of chronic low back painPain, 2011
- The Epidemiology of low back painBest Practice & Research Clinical Rheumatology, 2010
- Low Back Pain in Primary CareSpine, 2010
- Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind studyCurrent Medical Research and Opinion, 2005
- Prescription of Nonsteroidal Anti-inflammatory Drugs and Muscle Relaxants for Back Pain in the United StatesSpine, 2004
- Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trialScandinavian Journal of Rheumatology, 2004
- Lost Productive Time and Cost Due to Common Pain Conditions in the US WorkforceJAMA, 2003
- Epidemiological features of chronic low-back painThe Lancet, 1999